In Silico Discovery of GPCRs and GnRHRs as Novel Binding Receptors of SARS-CoV-2 Spike Protein Could Explain Neuroendocrine Disorders in COVID-19Mahmoud Elkazzaz, Israa M. Shamkh, Amr Ahmed et al.|Vaccines|2022Cited by 17
In silico discovery of GPCRSs and GnRHRs as Novel SARS-CoV-2 binding receptors, the Scientific Breakthrough that could explain the observed High cortisol, Appetite loss, Ansomnia and Hypogonadism, as well as Hypothyroidism, Retinol deficiency and menstrual disturbances among SARS-COV-2 patients.Mahmoud Elkazzaz, Tamer Haydara, Amr Ahmed et al.|Research Square|2021Cited by 5
AI-driven Discovery of Celecoxib and Dexamethasone for Exploring their Mode of Action as Human Interleukin (IL-6) Inhibitors to Treat COVID-19-induced Cytokine Storm in HumansIsraa M. Shamkh, Amr Ahmed, Mahmoud Elkazzaz et al.|Current Pharmaceutical Design|2023Cited by 5
Discovery of the Retinol STRA6 Receptor as a Novel Binding Receptor for SARS-CoV-2 in COVID-19: In Silico Research.Mahmoud Elkazzaz, Amr Ahmed, Tamer Haydara et al.|Research Square|2021Cited by 5
STRA6, as A Novel Binding Receptor of COVID-19, A Breakthrough That could Explain COVID-19 Symptoms with Unknown Aetiology.Mahmoud Elkazzaz, Amr Ahmed, Tamer Haydara et al.|Research Square|2021Cited by 4